Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
Viking Holdings Ltd Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 21.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Viking Holdings Ltd Ordinary Shares is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.

NUVBVIK
Market Cap
$1.71B$36.29B
Volume
5,448,7122,522,956
Sector
HealthConsumer Cyclical
52-Week High
$9.54$108.26
52-Week Low
$3.41$57.08
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.30B$38.67B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
VIK
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About Viking Holdings Ltd Ordinary Shares

Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.

Read more on VIK →